Page 109 - Mployee Wellness Programs News Today

Hello Alpha launched Ahead with Alpha, a weight management program for employers. It offers access to primary care providers trained in obesity care, medication management through weight loss drugs like GLP-1s, nutrition counseling with a registered dietitian and progress tracking. 

As clinical psychologists, we talk about therapy as the gold standard. I’m not saying it isn’t, but if only a minority of people are getting it, we need to broaden our perspective.

OptumRx's Chief Clinical Officer shares his insights on the latest developments and trends he's seen in the healthcare industry.

Biopharma companies are harnessing AI tools for multiple aspects of drug development such as identifying drug development targets, modeling a drug's effect on the body, and more.

Kindbody is now on Quantum Health’s Comprehensive Care Solutions platform, which offers a selection of benefits solutions that the company’s more than 500 employer clients can choose to contract with.

Amazon recently unveiled HealthScribe, an API that software companies can use to create clinical note generation apps that providers can later adopt. With this approach, Amazon is seeking to collaborate with companies that are building clinical documentation AI apps rather than compete with them. Some think this approach is clever, but others think it does little to facilitate bi-directional EHR integration and create standardization.

Just 10% of women who had post-miscarriage depression during the pandemic received the “full spectrum of treatment” through therapy and antidepressants, according to a new report by Evernorth Research Institute.

The average cost of a healthcare data breach is now $10.93 million, up from $10.10 million in 2022, according to a new report. Healthcare has the highest data breach costs of all industries — breaches are second costliest in the financial sector, where the average cost is $5.9 million.

The FDA approved RiVive, an over-the-counter version of naloxone nasal spray from Harm Reduction Therapeutics. It’s the second such approval from the FDA this year, following an affirmative decision in March for OTC Narcan.

Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.